Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;70(12):001462.
doi: 10.1099/jmm.0.001462.

JMM Profile: Carbapenems: a broad-spectrum antibiotic

Tom Armstrong  1 , Samuel Jacob Fenn  2 , Kim R Hardie  2
Affiliations
Review

JMM Profile: Carbapenems: a broad-spectrum antibiotic

Tom Armstrong et al. J Med Microbiol. 2021 Dec.

Abstract

Carbapenems are potent members of the β-lactam family that inhibit bacterial cell-wall biosynthesis inhibitors . They are highly effective against Gram-negative and Gram-positive drug-resistant infections . As such, carbapenems are typically reserved as an antibiotic of last resort. The WHO lists meropenem as an essential medicine. Nausea and vomiting are reported in ≤20% of carbapenem recipients, with 1.5% suffering seizures. Enzymatic hydrolysis of the β-lactam ring is the main driver of clinical resistance. These enzymes can be classified as Class A, B and D. Classes A and D are serine β-lactamases, whereas Class B rely on metal-mediated hydrolysis, typically through zinc.

Keywords: antimicrobial resistance; last resort; β-lactams.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Structure of commonly administered carbapenems in comparison to the β-lactam penicillin V.
Fig. 2.
Fig. 2.
The spectrum and mode of action, plus resistance mechanisms, for carbapenems. Carbapenems enter the bacterial envelope (I) and interact with penicillin binding proteins (PBPs) to disrupt cell-wall biosynthesis leading to cell death (II). Porin downregulation prevents drug molecules from reaching the cellular environment (III). Production of low-affinity PBPs can create resistant strains (IV). Enzymatic hydrolysis of the β-lactam ring deactivates the drug compounds (VI). Upregulation of efflux pumps effectively removes the cytotoxic payload from the cell, reducing (or negating) its therapeutic effects (V).
Fig. 3.
Fig. 3.
The spectrum of action, side effects and route of delivery for carbapenems.
See this image and copyright information in PMC

References

    1. Kahan JS, Kahan FM, Goegelman R, Currie SA, Jackson M, et al. Thienamycin, a new beta-lactam antibiotic. i. discovery, taxonomy, isolation and physical properties. J Antibiot. 1979;32:1–12. doi: 10.7164/antibiotics.32.1. - DOI - PubMed
    1. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55:4943–4960. doi: 10.1128/AAC.00296-11. - DOI - PMC - PubMed
    1. Trebosc V, Schellhorn B, Schill J, Lucchini V, Bühler J, et al. In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms. J Antimicrob Chemother. 2020;75:3552–3562. doi: 10.1093/jac/dkaa370. - DOI - PMC - PubMed
    1. Yocum RR, Rasmussen JR, Strominger JL. The mechanism of action of penicillin. Penicillin acylates the active site of Bacillus stearothermophilus D-alanine carboxypeptidase. J Biol Chem. 1980;255:3977–3986. - PubMed
    1. Codjoe FS, Donkor ES. Carbapenem resistance: a review. Medical Sciences. 2017;6:1. doi: 10.3390/medsci6010001. - DOI - PMC - PubMed